Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin-glucose solution during the preanhepatic phase of orthotopic liver transplantation
IRCT20240606062025N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin and dextrose in hepatic disease (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Post-operative complications, Tracheal extubation and 7 more. Started Jun 2024; status: completed.
02
Drugs
human insulindextrose
03
Conditions
hepatic disease
Beyond the preview
Go deeper on IRCT20240606062025N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240606062025N1.